Taylor A, Peltier C Z, Torre F J, Hakamian N
Laboratory for Nutrition and Vision Research, USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111.
Biochemistry. 1993 Jan 26;32(3):784-90. doi: 10.1021/bi00054a007.
Aminopeptidases catalyze the hydrolysis of amino acid residues from the amino terminus of peptide substrates. Their activity has been implicated in myriad fundamental biochemical and physiological processes, and alterations in aminopeptidase activity have been correlated with a variety of pathologies. Nevertheless, information about this group of proteases is less well developed. Bovine lens leucine aminopeptidase (blLAP) can be considered prototypical of many enzymes in this family of peptidases. It shows common features of (1) requiring divalent metal ions for activity, (2) having a relatively large size, and (3) having slow, relatively tight binding of bestatin, a transition-state analog of the substrate PheLeu. Bovine lens LAP is the only bestatin-inhibitable aminopeptidase for which structural and mechanistic data are available. However, full exploitation of these data required knowledge of the number of inhibitor molecules bound per subunit. Independent direct binding experiments and kinetic determinations indicate that one bestatin is bound per subunit in blLAP. Ki and Ki* for formation of the initial and final complexes are approximately 1.1 x 10(-7) and 1.3 x 10(-9) M, respectively. The mode of binding is slow and competitive. The t1/2 for formation and deformation of the final enzyme-inhibitor complex is approximately 30 and 22 min, respectively, with 10(-8) M bestatin. To perform these measures, a new assay using physiological peptides (LeuGlyGly) as substrate was adapted. Taken together with prior NMR, photoaffinity labeling, and crystallographic data, these binding data allow us to propose a mechanism of the blLAP-catalyzed hydrolysis of peptides.
氨肽酶催化从肽底物氨基末端水解氨基酸残基。它们的活性与无数基本生化和生理过程有关,氨肽酶活性的改变与多种病理状况相关。然而,关于这组蛋白酶的信息尚不完善。牛晶状体亮氨酸氨肽酶(blLAP)可被视为该肽酶家族中许多酶的典型代表。它具有以下共同特征:(1)活性需要二价金属离子;(2)相对较大;(3)对底物苯丙氨酸亮氨酸的过渡态类似物苯丁抑制素具有缓慢、相对紧密的结合。牛晶状体LAP是唯一有结构和机制数据的可被苯丁抑制素抑制的氨肽酶。然而,要充分利用这些数据需要了解每个亚基结合的抑制剂分子数量。独立的直接结合实验和动力学测定表明,blLAP中每个亚基结合一个苯丁抑制素。初始和最终复合物形成的Ki和Ki*分别约为1.1×10⁻⁷和1.3×10⁻⁹ M。结合模式缓慢且具有竞争性。用10⁻⁸ M苯丁抑制素时,最终酶-抑制剂复合物形成和变形的t1/2分别约为30分钟和22分钟。为了进行这些测量,采用了一种以生理肽(亮氨酸甘氨酸甘氨酸)为底物的新测定方法。结合先前的核磁共振、光亲和标记和晶体学数据,这些结合数据使我们能够提出blLAP催化肽水解的机制。